Orla Hardiman
Tracked across 1 events · 6 articles · First seen Aug 18, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Cumulus Neuroscience announced the publication of final results from its CNS-102 study in Scientific Reports, demonstrating that its at-home NeuLogiq Platform is feasible, well tolerated, and highly usable for multimodal cognitive assessment in people living…
Impact: Orla Hardiman is the Lead Investigator of PRECISIONALS and Principal Investigator of CNS-102. Her endorsement adds credibility to the study's findings.
Aug 18, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Orla Hardiman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard